Deep Margin

Prof Evans joins us live from sunny Wales to give us the lowdown on TNM 9 and where it sits. This will give Ben and Will something to talk about at parties.

Professor Neil Gross from MD Anderson talks us through his absolutely seminal work in the field of cutaneous SCCs and what this looks like for the head and neck community. Cemiplimab, EMPOWER, C-POST, neaodjuvant strategies - something for all the family.

Professor Terry Jones, Professor of Head and Neck surgery in Liverpool UK talks us throught the PATHOS trial. Pathos is Greek for "suffering," "experience," or "emotion" and he's shares his work on the trial!

Another rockstar joins us for a great episode talking through some of the advances in head and neck de-escalation

We're back with Chris Holsinger for part 2 of the TORS adventure

Alan Ho, Medical oncologist at MSKCC talks us through his work around Ozuriftamab Vedotin (Oz-V) and other ADC approaches. Ben criticises Will's combination approaches.

Nadeem Riaz directs the Precision Radiotherapy Initiative and leads a multidisciplinary research lab at the intersection of the DNA damage response and anti-tumor immunity. He talks us through his important paper examining mechanisms of resistance and some of the pitfalls of academia.

Yungan Tao President-Elect GORTEC, and Radiation Oncologist in Head and Neck cancer at Institut Gustave-Roussy talks us through the NICOPOSTOP trial. Will risks diplomatic incidents and out European tour continues.

Pierre Blanchard, Professor at Gustave Roussy and Editor of Radiotherapy and Oncology 'the green journal' joins us to discuss his recent trial

Professor and Vice-chair of Hematology and Medical Oncology, and Professor of Otolaryngology at the Winship Cancer Institute at the Emory University School of Medicine in Atlanta, Georgia. He talks us through sinonasal histologies . Ben refers Will to social services.

Superstar Kate Hutcheson, Professor in the  Department of Head and Neck Surgery at The University of Texas MD Anderson  Cancer Center. and Director of Speech Pathology and Audiology talks to us about long term outcomes and examines Will's literacy.

Chris Holsinger from Stanford gets grilled by Ben and Will on TORS history in this part 1/2 episode.

We talk ORATOR, ORATOR 2 and the genesis of evidence in TORS!

Melvin Chua joins the deeply marginal crowd to talk EBV ctDNA, its clinical use, science, gardening and islands.

Chris Nutting, Professor of Radiotherapy and leader on many pivotal trials at the ICR joins us to talk through the past 25 years of radiotherapy advances and the data underpinning these. We talk about the future and Will has some technical difficulties so there is less nonsense than usual!

Dr Glenn Hanna, Director of the Center for Cancer Therapeutic Innovation (CCTI) at Dana Faber Cancer Insitute joins us for our 10th episode and it's a cracker; Glenn talks us through the finer points of ctDNA, MRD and what the future holds for this exciting space.  

Professor Vin Paleri, Consultant Head and Neck Surgeon at The Royal Marsden Hospitals and Professor of Head and Neck Surgery at the Institute of Cancer Research talks us through salvage surgery data, patient selection and how to tame feral oncologists.

Paul Swieciki, Associate Professor from Michigan joins us for a deep dive into bispecifics. We talk future targets, current excitiement and Ben gets excited about merchandise and a potential grudge match with friend of the show hardman Ari Rosenberg. It's a belter!